Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 19

Urolithin A nudges aging immune cells toward a youthful profile in 28 days

An international research team focused on aging reports that urolithin A at 1,000 mg per day shifted human immune profiles toward a more naive-like, less exhausted CD8+ state and increased fatty acid oxidation capacity, with additional functional gains.

Urolithin A is a metabolite produced by gut bacteria after breaking down ellagic acid from certain foods, such as pomegranates and walnuts. While produced naturally through microbial digestion, it is in much smaller quantities than available as a supplement or used in the study.

Aging bodies face reduced production of mature T cells, shrinking naive T cell pools and chronic low-grade inflammation. Mitochondrial dysfunction and waning autophagy sit at the core of these shifts, with mitophagy failure linked to immune dysregulation and disease.

One of the world’s oldest blood pressure drugs may also halt aggressive brain tumor growth

A Penn-led team has revealed how hydralazine, one of the world’s oldest blood pressure drugs and a mainstay treatment for preeclampsia, works at the molecular level. In doing so, they made a surprising discovery—it can also halt the growth of aggressive brain tumors.

Over the last 70 years, hydralazine has been an indispensable tool in medicine—a front-line defense against life-threatening , especially during pregnancy. But despite its essential role, a fundamental mystery has persisted: No one knows its “mechanism of action”—essentially how it works at a molecular level, which allows for improved efficacy, safety, and what it can treat.

“Hydralazine is one of the earliest vasodilators ever developed, and it’s still a first-line treatment for preeclampsia—a hypertensive disorder that accounts for 5%–15% of worldwide,” says Kyosuke Shishikura, a physician-scientist at the University of Pennsylvania. “It came from a ‘pre-target’ era of , when researchers relied on what they saw in patients first and only later tried to explain the biology behind it.”

From body fat to bone, experiment offers hope for ‘gentle’ repair of fractures

Japanese researchers are testing a surprising, minimally invasive way to repair spine fractures.

A team at Osaka Metropolitan University found that stem cells from can repair breaks similar to those common in people with the bone-weakening disease osteoporosis.

“This simple and effective method can treat even difficult fractures and may accelerate healing,” said study co-leader Dr. Shinji Takahashi, an orthopedic surgeon and clinical lecturer at the university.

Bridging Retinal and Cerebral Neurodegeneration: A Focus on Crosslinks between Alzheimer–Perusini’s Disease and Retinal Dystrophies

In the early stages of Alzheimer–Perusini’s disease (AD), individuals often experience vision-related issues such as color vision impairment, reduced contrast sensitivity, and visual acuity problems. As the disease progresses, there is a connection with glaucoma and age-related macular degeneration (AMD) leading to retinal cell death. The retina’s involvement suggests a link with the hippocampus, where most AD forms start. A thinning of the retinal nerve fiber layer (RNFL) due to the loss of retinal ganglion cells (RGCs) is seen as a potential AD diagnostic marker using electroretinography (ERG) and optical coherence tomography (OCT). Amyloid beta fragments (Aβ), found in the eye’s vitreous and aqueous humor, are also present in the cerebrospinal fluid (CSF) and accumulate in the retina. Aβ is known to cause tau hyperphosphorylation, leading to its buildup in various retinal layers.

The role of intestinal microbiota and its metabolite short-chain fatty acids in hypertriglyceridemia-associated acute pancreatitis

Hypertriglyceridemia-associated acute pancreatitis (HLAP) is a severe gastrointestinal condition characterized by an increased risk of multiple organ dysfunction and elevated mortality. Intestinal microbiota, often described as the second human genome, plays a key role in maintaining gastrointestinal and systemic homeostasis. Among its various metabolites, short-chain fatty acids (SCFAs) are particularly abundant and functionally significant. Current evidence indicates a strong relationship between SCFAs and the pathogenesis and progression of HLAP. SCFAs contribute to the restoration of intestinal homeostasis by modulating the composition of gut microbiota, enhancing the integrity of the intestinal epithelial barrier, and regulating mucosal immune responses. Furthermore, SCFAs attenuate systemic inflammatory responses, promote pancreatic tissue repair, and reduce the risk of multiple organ dysfunction. These protective effects indicate that SCFAs represent a promising therapeutic target for gut-centered interventions in HLAP. This review summarizes the changes in intestinal microbiota and SCFA levels following HLAP onset, elucidates the underlying mechanisms by which SCFAs exert protective effects, and evaluates their potential therapeutic applications, thereby providing a theoretical basis for the development of gut-targeted strategies in the management of HLAP.

Acute pancreatitis (AP) is characterized by acute inflammation and cellular injury within the pancreas and is recognized as a common cause of acute abdominal disorders. With improvements in living standards and shifts in dietary habits, the incidence of hypertriglyceridemia-associated acute pancreatitis (HLAP) has significantly increased, surpassing alcoholic pancreatitis to become the second leading cause of AP (Chinese Pancreatic Surgery Association, and Chinese Society of Surgery, Chinese Medical Association, 2021). Additionally, HLAP is increasingly observed in younger adults and is associated with severe clinical presentations, including a higher incidence of complications such as acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), and multiple organ dysfunction syndrome (MODS) (Li et al., 2018).

A Radical New Kind of Particle Accelerator Could Transform Science

A particle accelerator that produces intense X-rays could be squeezed into a device that fits on a table, my colleagues and I have found in a new research project.

The way that intense X-rays are currently produced is through a facility called a synchrotron light source. These are used to study materials, drug molecules, and biological tissues. Even the smallest existing synchrotrons, however, are about the size of a football stadium.

Our research, which has been accepted for publication in the journal Physical Review Letters, shows how tiny structures called carbon nanotubes and laser light could generate brilliant X-rays on a microchip. Although the device is still at the concept stage, the development has the potential to transform medicine, materials science, and other disciplines.

Scientists tie lupus to a virus nearly all of us carry

One of humanity’s most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic lupus erythematosus (lupus), Stanford Medicine investigators and their colleagues have found.

The Epstein-Barr virus (EBV), which resides silently inside the bodies of 19 out of 20 Americans, is directly responsible for commandeering what starts out as a minuscule number of immune cells to go rogue and persuade far more of their fellow immune cells to launch a widespread assault on the body’s tissues, the scientists have shown.

The work is published in the journal Science Translational Medicine.

New technique enables faster drug design for diseases linked to ion channels

An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the Spanish National Research Council, has developed a new technique that will accelerate the design of drugs that target ion channels, a type of cell membrane protein involved in numerous diseases, ranging from psychiatric disorders to various types of cancer.

The research, carried out in collaboration with the University of East Anglia and the Qadram Institute (both in the United Kingdom), has been published in the Journal of the American Chemical Society.

Ion channels are cell membrane proteins that regulate the passage of ions into the cell. They are essential in processes as diverse as nerve transmission, and and their dysfunction is associated with numerous disorders, making them therapeutic targets of great interest.

Exercise-induced vesicles boost neuron growth when transplanted into sedentary mice

Researchers at the University of Illinois Urbana-Champaign report that extracellular vesicles released into the bloodstream during aerobic exercise can, on their own, drive a robust increase in adult hippocampal neurogenesis when transferred into sedentary mice, even without changes in hippocampal vascular coverage.

Aerobic physical activity preserves cognitive function across the lifespan and repeatedly links to structural and cellular plasticity in the hippocampus. Evidence from plasma transfer experiments indicates that bloodborne factors from exercising animals can transfer pro-neurogenic and pro-cognitive effects to sedentary or aged recipients, partly through reduced inflammation.

Many circulating molecules have been implicated in this exercise–brain connection, including , insulin-like growth factor 1, platelet factor 4, selenoprotein P, irisin, cathepsin B, L-lactate, and interleukin-6. Each contributes to specific aspects of neurogenesis or neuronal survival.

Software optimizes brain simulations, enabling them to complete complex cognitive tasks

A new software enables brain simulations which both imitate the processes in the brain in detail and can solve challenging cognitive tasks. The program was developed by a research team at the Cluster of Excellence “Machine Learning: New Perspectives for Science” at the University of Tübingen. The software thus forms the basis for a new generation of brain simulations which allow deeper insights into the functioning and performance of the brain. The Tübingen researchers’ paper has been published in the journal Nature Methods.

For decades, researchers have been trying to create computer models of the brain in order to increase understanding of the organ and the processes that take place there. Using , they have simulated the behavior and interaction of nerve cells and their compounds.

However, previous models had significant weaknesses: They were either based on oversimplified neuron models and therefore strayed significantly from biological reality, or they depicted the biophysical processes within cells in detail, but were incapable of carrying out similar tasks to the brain.

/* */